AMARIN CORP PLC\UK Increase (Decrease) in Other Current Assets
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Other Current Assets of $1.37 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2014-11-06
- AMARIN CORP PLC\UK increase (decrease) in other current assets for the quarter ending 2014-09-30 was $59.00K, a 95.68% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in other current assets for the quarter ending 2014-06-30 was -$68.00K.
- AMARIN CORP PLC\UK increase (decrease) in other current assets for the quarter ending 2014-03-31 was $1.38M, a 63.67% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in other current assets for the quarter ending 2013-12-31 was -$1.97M.
- AMARIN CORP PLC\UK increase (decrease) in other current assets for fiscal 2013 was -$1.69M, a 219.35% decline from fiscal 2012.
- AMARIN CORP PLC\UK increase (decrease) in other current assets for fiscal 2012 was $1.42M, a 82.95% increase from fiscal 2011.
- AMARIN CORP PLC\UK increase (decrease) in other current assets for fiscal 2011 was $774.00K.
- AMARIN CORP PLC\UK increase (decrease) in other current assets for fiscal 2010 was -$912.00K, a 1441.18% decline from fiscal 2009.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2014-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$9.00K derived: sum of 2 quarters · filed 2014-11-06 | $1.37M 10-Q · filed 2014-11-06 | -$602.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.31M 10-Q · filed 2014-08-07 | -$661.00K derived: sum of 3 quarters · filed 2014-08-07 | $704.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-03-31 | $1.38M 10-Q · filed 2014-05-09 | -$593.00K derived: sum of 2 quarters · filed 2014-05-09 | $772.00K derived: sum of 3 quarters · filed 2014-11-06 | -$4.11M derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$608.00K derived: sum of 2 quarters · filed 2014-11-06 | -$5.49M derived: sum of 3 quarters · filed 2014-11-06 | -$1.69M 10-K · filed 2014-02-27 |
| 2013-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$3.52M derived: sum of 2 quarters · filed 2014-11-06 | $283.00K 10-Q · filed 2014-11-06 | -$574.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | -$4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$1.08M 10-Q · filed 2014-08-07 | -$1.94M derived: sum of 3 quarters · filed 2014-08-07 | -$4.26M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $3.80M 10-Q · filed 2014-05-09 | $2.94M derived: sum of 2 quarters · filed 2014-05-09 | $618.00K derived: sum of 3 quarters · filed 2014-05-09 | $2.08M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | -$857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$3.18M derived: sum of 2 quarters · filed 2014-02-27 | -$1.72M derived: sum of 3 quarters · filed 2014-02-27 | $1.42M 10-K · filed 2014-02-27 |
| 2012-09-30 | -$2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$858.00K derived: sum of 2 quarters · filed 2013-11-07 | $2.27M 10-Q · filed 2013-11-07 | $1.50M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $4.60M 10-Q · filed 2013-08-08 | $3.83M derived: sum of 3 quarters · filed 2014-02-27 | $5.91M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $3.13M 10-Q · filed 2013-05-09 | $2.36M derived: sum of 2 quarters · filed 2014-02-27 | $4.44M derived: sum of 3 quarters · filed 2014-02-27 | $4.49M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$769.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $1.31M derived: sum of 2 quarters · filed 2014-02-27 | $1.36M derived: sum of 3 quarters · filed 2014-02-27 | $774.00K 10-K · filed 2014-02-27 |
| 2011-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.13M derived: sum of 2 quarters · filed 2012-11-08 | $1.54M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$535.00K 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | -$586.00K 10-Q · filed 2012-05-08 | |||
| 2010-12-31 | -$912.00K 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $68.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |